CROMA POLYPHIL™ HAIR
Name: CROMA POLYPHIL™ HAIR
Manufacturer: Croma
Active Substance(s): PN-HPT®
Strength: 15mg/2ml
Package Content: 1 x 2ml Pre-Filled Syringes
In Stock
CROMA POLYPHIL™ HAIR is Croma-Pharma’s 15mg/2ml scalp polynucleotide (PN-HPT®) injectable, formulated to support the follicular microenvironment, scalp microcirculation, and the hair growth cycle across multi-session restoration protocols. Sold internationally as PhilArt Hair, it works alongside pharmaceutical hair-loss therapies rather than replacing them.
Specifications
Description
Name: CROMA POLYPHIL™ HAIR
Manufacturer: Croma
Active Substance(s): PN-HPT®
Strength: 15mg/2ml
Package Content: 1 x 2ml Pre-Filled Syringes
CROMA POLYPHIL™ HAIR 15mg/2ml Injection — PN-HPT® Polynucleotide Scalp Booster for Hair Loss & Follicular Regeneration
Loss & Follicular Regeneration
CROMA POLYPHIL™ HAIR is Croma-Pharma’s 15mg/2ml scalp presentation in the PN-HPT® polynucleotide range, developed to support the follicular microenvironment across staged hair-restoration protocols. The same syringe is sold internationally as PhilArt Hair. Clinicians, trichologists, and consumers looking to buy CROMA POLYPHIL™ HAIR for androgenetic alopecia, telogen effluvium, or general hair thinning can order it directly through Direct Doctor Supply, a trusted supplier since 2014.
Product Specifications
- Strength: 15mg/2ml PN-HPT® polynucleotide
- Active ingredient: PN-HPT® highly purified long-chain sodium polynucleotides, extracted from salmonidae (salmon and trout) sperm DNA. Screen carefully for documented severe fish or seafood allergy before treatment to avoid systemic hypersensitivity events
- Dosage form: injectable gel; 1 x 2ml pre-filled syringe with sterile 30G ½” needles (32G–33G preferred by many injectors for scalp comfort)
- Manufacturer: Croma-Pharma GmbH, Austria
- Brand: CROMA POLYPHIL™ HAIR (also marketed internationally as PhilArt Hair)
- Country of origin: Austria
- Regulatory status: CE-marked Class III aesthetic injectable medical device (EU) [1]. Not FDA-cleared or approved for aesthetic use in the United States. MHRA (UK), TGA (Australia), and Health Canada availability varies and should be verified at the time of order
- Intended use: intradermal scalp injection for hair-restoration protocols across androgenetic alopecia, telogen effluvium, and general hair thinning. Off-label practitioner-discretion use for eyebrow density is also reported
- Storage: store between 2 and 25°C; do not freeze; protect from light
What Makes CROMA POLYPHIL™ HAIR Different?
Polynucleotide Biostimulation for the Scalp
Most established hair-loss therapies work at the follicle itself. Minoxidil widens perifollicular vessels, finasteride blocks 5-alpha-reductase, and PRP delivers concentrated autologous growth factors. CROMA POLYPHIL™ HAIR targets a different layer — the follicular microenvironment. It’s a polynucleotide scalp booster designed to improve dermal density, microcirculation, and anti-inflammatory tone around each follicle, complementing rather than competing with the pathways those drugs act on.
For CROMA POLYPHIL™ HAIR vs PRP, both use scalp micro-injection to reshape the tissue environment. PN-HPT® delivers a standardized formulation from batch to batch, while PRP quality is patient-specific and centrifuge-dependent. Some clinicians combine the two approaches in the same program.
For CROMA POLYPHIL™ HAIR vs PLINEST® HAIR, both are polynucleotide scalp injectables from different manufacturers (Croma-Pharma and Mastelli) with distinct formulation heritage. Direct Doctor Supply carries both, and clinicians expanding a hair-restoration menu often buy polynucleotides across the category before committing to one line.
Indications & Treatment Areas
-
- Mild-to-moderate androgenetic alopecia in men and women, typically addressed earlier in the trajectory
- Telogen effluvium, both acute and chronic shedding patterns
- General hair thinning and reduced density
- Adjunctive layering alongside minoxidil, finasteride, or PRP programs
- Eyebrows, as off-label practitioner-discretion use (not an explicit IFU indication)
In CROMA POLYPHIL™ HAIR for androgenetic alopecia protocols, injection is placed intradermally into the affected scalp zones — frontal, vertex, and mid-scalp being most common — following the pattern of loss. Clinics running multi-patient hair-restoration programs regularly buy CROMA POLYPHIL™ HAIR wholesale so per-syringe cost stays stable across a course. Practitioners also stocking topical or oral therapies often buy hair loss treatments from the same distributor to consolidate ordering.
CROMA POLYPHIL™ HAIR Polynucleotide Mechanism of Action
Delivered into the scalp dermis by ultra-fine needle, PN-HPT® polynucleotides act as a temporary scaffold for local tissue repair and as the substrate that endogenous enzymes gradually break down into nucleoside and nucleotide fragments. Those fragments engage adenosine receptors on fibroblasts. A2A activation is the primary pathway cited for fibroblast proliferation and type I collagen and elastin synthesis in the perifollicular dermis, which anchors each follicle and buffers the microcirculation feeding it [2].
The same fragments engage A2B adenosine receptors, which modulate perifollicular vascularity and VEGF expression, supporting the microvascular supply that feeds each follicle. The polynucleotide chain also acts as an antioxidant buffer against reactive oxygen species that accumulate in inflamed or aging scalp tissue, while the released fragments feed the nucleotide salvage pathway, where resident cells reuse them for endogenous DNA repair.
Improved scalp microcirculation combined with the anti-inflammatory activity of PN-HPT® is relevant to shedding patterns with a low-grade inflammatory component.
CROMA POLYPHIL™ HAIR Treatment Protocol & Administration
A typical CROMA POLYPHIL™ HAIR protocol runs in three phases:
- Induction Phase: Covers weekly sessions during weeks 1 to 4
- Intermediate Phase: Sessions spaced every 2 to 3 weeks for a further 1 to 2 months.
- Maintenance Phase: Generally scheduled every 3 to 6 months. Practitioners should verify exact intervals and volumes against the current Croma-Pharma IFU [1].
Common injection technique options include microdroplet distribution across the treatment area, linear injection along defined scalp rows, and fan-pattern coverage for broader zones. Volume per session is distributed across the affected areas per the treatment map.
The package supplies 30G half-inch needles, though many injectors switch to 32G or 33G for scalp comfort. Store the syringe at 2 to 25°C, protect from light, do not freeze, and maintain standard aseptic technique. Administration is by a qualified injector only. Patients should avoid vigorous scalp friction, saunas, and strenuous exercise for the first 24 hours and delay hair washing per practitioner guidance.
CROMA POLYPHIL™ HAIR Benefits & Expected Results Timeline
Outcomes build across the staged course. In sessions 1 and 2, some patients report reduced shedding and improved scalp comfort. From sessions 3 through 6, measurable change in hair density and follicular quality tends to appear, consistent with the gradual pace of biostimulatory therapy [1].
Post-induction improvements are typically maintained for three to six months with continued maintenance, with individual variation depending on baseline hair condition, hormonal drivers, and any adjunctive therapies in place [1]. Long-term preservation, particularly in androgenetic alopecia, usually requires layering the polynucleotide protocol onto ongoing pharmaceutical or PRP therapy rather than treating it as monotherapy. Individual outcomes vary and are not guaranteed.
CROMA POLYPHIL™ HAIR Side Effects & Safety
Reported side effects are usually mild and self-limiting [1]. Common effects include mild erythema, tenderness, and small papules at injection sites, generally resolving within a few days. Scalp-specific effects include transient headache or scalp tightness for 24 to 48 hours in some patients. Rare but serious risks include infection and hypersensitivity reactions, which warrant prompt clinical attention.
Contraindications include active scalp infection or inflammatory dermatosis and known hypersensitivity to polynucleotides. Because PN-HPT® is extracted from salmon and trout DNA, patients with documented severe fish or seafood allergy should be screened carefully before treatment. Follow the current IFU for pregnancy and lactation, and assess autoimmune conditions case by case.
The CROMA POLYPHIL™ Product Family
CROMA POLYPHIL™ HAIR 15mg/2ml sits alongside three other members of Croma-Pharma’s polynucleotide range. The 40mg/2ml (20 mg/ml) general-use flagship, CROMA POLYPHIL™, is used for face, neck, and body biorevitalization. CROMA POLYPHIL™ EYE is a 15mg/2ml periocular presentation for dark circles, tear troughs, and crow’s feet. CROMA POLYPHIL™ NEXT is a hybrid syringe containing 20 mg/2ml polynucleotide (10 mg/ml) plus 20 mg/2ml non-crosslinked hyaluronic acid (10 mg/ml), positioned for deeper tissue applications.
Mastelli’s PLINEST® HAIR is the closest competing scalp polynucleotide and is also stocked by Direct Doctor Supply.
Where to Buy CROMA POLYPHIL™ HAIR Online — Direct Doctor Supply
Direct Doctor Supply carries CROMA POLYPHIL™ HAIR for aesthetic clinics offering hair-restoration services and for individual buyers researching options for a personal treatment plan arranged with a qualified injector. Before you purchase CROMA POLYPHIL™ HAIR online through any distributor, make sure to verify the following:
- LOT number traceability
- Certificate of authenticity
- Cold-chain integrity in transit
- Distributor’s own credentials.
Buy CROMA POLYPHIL™ HAIR Wholesale from Direct Doctor Supply
Direct Doctor Supply ships authentic, manufacturer-sourced CROMA POLYPHIL™ HAIR at wholesale pricing with tiered volume discounts, packaged for cold-chain transit and tracked in shipping. Formerly known as Maylips.com, the supplier has served the same buyer base since 2014. Clinics running multi-patient hair-restoration programs can buy CROMA POLYPHIL™ HAIR wholesale to keep per-syringe cost stable across the induction and maintenance schedule, and individual buyers can add single syringes to the same order.
For ordering questions, wholesale enquiries, bulk procurement across the CROMA POLYPHIL™ family, or shipping updates, message the Direct Doctor Supply support team.
Legal & Regulatory Status
CROMA POLYPHIL™ HAIR is a CE-marked Class III aesthetic injectable medical device manufactured in Austria by Croma-Pharma GmbH. Polynucleotide and PDRN aesthetic injectables are not FDA-cleared or approved for cosmetic use in the United States. Regional availability under the UK MHRA, Australian TGA, and Health Canada frameworks varies and should be verified at the time of order (accurate as of 2026). Administration is intended for trained injectors. Direct Doctor Supply supplies both licensed practitioners and consumers who arrange administration through a qualified provider.
What is CROMA POLYPHIL™ HAIR?
A CE-marked PN-HPT® polynucleotide scalp injectable from Croma-Pharma at 15mg/2ml, formulated for hair-restoration protocols.
What is CROMA POLYPHIL™ HAIR used for?
Scalp injection supporting androgenetic alopecia, telogen effluvium, and hair thinning, often layered onto minoxidil, finasteride, or PRP. Off-label use for eyebrow density is also reported.
How does CROMA POLYPHIL™ HAIR work?
PN-HPT® breaks down in the scalp dermis into nucleoside and nucleotide fragments that activate adenosine receptors on fibroblasts, chiefly A2A (driving collagen production) and A2B (modulating VEGF and perifollicular microvascular supply). Antioxidant scavenging and nucleotide salvage for DNA repair contribute in parallel.
Is CROMA POLYPHIL™ HAIR safe?
It has a favorable reported safety profile when administered by a qualified injector. Screen for documented severe fish or seafood allergy, since PN-HPT® is derived from salmon and trout DNA.
What can I expect from CROMA POLYPHIL™ HAIR before and after treatment?
Reported changes commonly include reduced shedding, improved scalp comfort, and gradual density improvement across the course. Individual outcomes vary and are not guaranteed.
How long does CROMA POLYPHIL™ HAIR last?
Post-induction improvements are usually maintained for three to six months with continued maintenance. Long-term preservation in androgenetic alopecia typically requires ongoing adjunctive therapy.
Where can I buy CROMA POLYPHIL™ HAIR online?
Direct Doctor Supply (formerly Maylips) has stocked authentic Croma-Pharma CROMA POLYPHIL™ HAIR for licensed practitioners and consumers since 2014, with wholesale pricing and tracked shipping. Reach the Direct Doctor Supply support team for ordering guidance.
All content on this website is intended for informational purposes and does not constitute medical advice.
Citations
[1] Cavallini, Maurizio et al. “Consensus report on the use of PN-HPT™ (polynucleotides highly purified technology) in aesthetic medicine.” Journal of cosmetic dermatology vol. 20,3 (2021): 922-928. doi:10.1111/jocd.13679
[2] Byun, Kyung-A et al. “Polynucleotides Enhance Collagen Synthesis via Modulating Phosphoenolpyruvate Carboxykinase 1 in Senescent Macrophages: Experimental Evidence.” International journal of molecular sciences vol. 26,17 8720. 7 Sep. 2025, doi:10.3390/ijms26178720
Important Information
Warning! The product is intended solely for professional use in a medical environment and under professional supervision. The product is supplied to medical professionals who specialize in aesthetic medicine (plastic surgery, facial treatments) and work under individual medical licenses as aestheticians or in dedicated clinics. Unprofessional use by individuals without a medical background may lead to severe adverse effects and health harm.
Direct Doctor Supply sources its inventory only through authorized distribution channels, so every order arrives sealed in the manufacturer’s original packaging. Our sourcing standards and tracked delivery mean you receive authentic original products every time.
Content prepared by Direct Doctor Supply’s editorial team.
Sourcing and accuracy for this page follow our Editorial Policy: claims are cross-checked against clinical literature, regulatory filings, and manufacturer specifications before anything is published.








